Congratulations to Dr. Henary on one of his compounds being licensed!
One of Dr. Henary’s compounds (MHI-148) has been licensed by DanZen Theranostics, a Delaware-based company, to develop a product that can be used to image and target cancer cells. Georgia State University has finalized the licensing agreement with this company.
Here is a link to the full story: https://news.gsu.edu/2018/10/01/georgia-state-signs-licensing-agreement-with-dazen-theranostics-inc-to-develop-product-that-can-target-image-and-destroy-cancer-cells/
Please join me in congratulating Dr. Henary on this achievement! It is always a dream of many chemists to see their compounds and inventions be put into use. This is great news for Dr. Henary’s research program, the Department of Chemistry, and Georgia State University.